๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Multiple Myeloma (MM)

Sleep Apnea in Patients With MGUS and MM NCT04114084n/a1 site๐Ÿ“ Iowa City Michael Tomasson ยท Tests: Bone Marrow Aspirate and Biopsy A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies NCT05908409Phase 1, Phase 211 sites๐Ÿ“ Santander๐Ÿ“ Salamanca๐Ÿ“ Barcelona IDP Discovery Pharma S.L. ยท Tests: IDP-121 An Open-label, Single-arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of OriV508 Injection in Treating Relapsed/Refractory Hematological Malignancies NCT07101705EARLY Phase 11 site๐Ÿ“ Wuhan Union Hospital, Tongji Medical College, Huazhong Universityโ€ฆ ยท Tests: OriV508 Injection A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With Daratumumab (Tec-Dara) in Newly Diagnosed Multiple Myeloma With Concurrent Light Chain Amyloidosis (MM+AL). NCT07638683Phase 21 site๐Ÿ“ Shanghai Shanghai Zhongshan Hospital ยท Tests: Teclistamab A Pilot Study of Soursop Tea in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Multiple Myeloma (MM) NCT07771803EARLY Phase 11 site๐Ÿ“ Camden Roger Strair ยท Tests: Soursop tea Safety and Efficacy of Anti-BCMA/FcRL5 CAR-T Cell Therapy in Treating Relapsed and Refractory Multiple Myeloma (R/R MM) NCT06759181Phase 1, Phase 21 site๐Ÿ“ Xuzhou Xuzhou Medical University ยท Tests: anti-BCMA/FcRL5 CAR T Gustabor Phase 2 - Treating Taste Changes During Cancer Therapy: A Randomized Study Evaluating an AI- Based Nutrition Intervention NCT07649681NA6 sites๐Ÿ“ Augsburg๐Ÿ“ Erlangen๐Ÿ“ Mรผnchen Wuerzburg University Hospital ยท Tests: Gustabor server, Standard Recommendations Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies NCT07648264Phase 360 sites๐Ÿ“ Orange๐Ÿ“ Denver๐Ÿ“ Coral Springs CSL Behring ยท Tests: IgPro20 Autologous Transplantation Combined With BCMA CAR-T in the Treatment of UHR-MM NCT07109323Phase 1, Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: BCMA CART Safety and Efficacy of Anti-FcRL5 CAR-T Cell Therapy in Treating Relapsed and Refractory Multiple Myeloma (R/R MM) NCT06196255Phase 1, Phase 21 site๐Ÿ“ Xuzhou Xuzhou Medical University ยท Tests: anti-FcRL5 CAR-T A Study Evaluating the Safety, Pharmacokinetics, and Activity of the Combination of Cevostamab and Elranatamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM) NCT05927571Phase 114 sites๐Ÿ“ Camperdown๐Ÿ“ Waratah๐Ÿ“ Adelaide Genentech, Inc. ยท Tests: Cevostamab, Elranatamab, Tocilizumab Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency NCT05879757n/a27 sites๐Ÿ“ Cรณrdoba๐Ÿ“ Pilsen๐Ÿ“ Prague Takeda ยท Tests: No Intervention All-trans Retinoic Acid in Combination With a KPD Regimen for the Treatment of Refractory/Relapsed Multiple Myeloma NCT06158412Phase 21 site๐Ÿ“ Xiamen The First Affiliated Hospital of Xiamen University ยท Tests: All-trans Retinoic Acid in combination with the KPD Regimen Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies NCT07270263NA1 site๐Ÿ“ Gdansk Medical University of Gdansk ยท Tests: Apixaban, Rivaroxaban, low molecular weight heparin (enoxaparin sodium) Personalising Treatment for Myeloma Patients Based on Initial Response to NHS Treatment and Their Overall Fitness Level NCT07649525Phase 35 sites๐Ÿ“ Bristol๐Ÿ“ Eastbourne๐Ÿ“ Leeds University of Leeds ยท Tests: Daratumumab, Lenalidomide, Dexamethasone, Teclistamab, Talquetamab CD38 Targeted -PET/ CT for Multiple Myeloma NCT07782944NA1 site๐Ÿ“ Guilin Guilin Medical University, China ยท Tests: standard-of-care imaging (FDG PET/CT), CD38 PET/CT Mezigdomide, Carfilzomib, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma in Patients With Extramedullary Disease NCT06627751Phase 21 site๐Ÿ“ Buffalo Roswell Park Cancer Institute ยท Tests: Mezigdomide, Carfilzomib, Dexamethasone, Echocardiography, Positron Emission Tomography A Phase 1 Study of Vaccination With Dendritic Cell (DC)/Multiple Myeloma (MM) Fusions in Combination With Elranatamab in Relapsed or Refractory Multiple Myeloma NCT06799026Phase 12 sites๐Ÿ“ Boston๐Ÿ“ Boston David Avigan ยท Tests: Elranatamab, GM-CSF, DC/MM Fusion Vaccine Determine the Frequency of Variants in the GBA/PSAP Genes in Patients With MM or MGUS NCT06559033n/a2 sites๐Ÿ“ Rouen๐Ÿ“ Rouen University Hospital, Rouen ยท Tests: Evaluation of the presence and number of mutated alleles of the GBA/PSAP genes in patients with MM or MGUS A Clinical Study to Evaluate the Safety and Preliminary Efficacy of QI-019A in Patients With Relapsed/Refractory Multiple Myeloma. NCT07429721EARLY Phase 11 site๐Ÿ“ Wuhan Union Hospital, Tongji Medical College, Huazhong Universityโ€ฆ ยท Tests: QI-019A Injection A Machine Learning Approach to Connect Multiple Myeloma Complexity to Early Disease Recurrence NCT06767254n/a4 sites๐Ÿ“ Meldola๐Ÿ“ Bologna๐Ÿ“ Cagliari IRCCS Azienda Ospedaliero-Universitaria di Bologna Randomised Controlled Trial of Artificial Intelligence-assisted Health Education NCT07305337NA1 site๐Ÿ“ Wuhan Zhongnan Hospital ยท Tests: Artificial Intelligence Health Education, Artificial health education A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPROยฎ in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma NCT07477587Phase 184 sites๐Ÿ“ Springdale๐Ÿ“ Jacksonville๐Ÿ“ Margate Shanghai Henlius Biotech ยท Tests: HLX15-SC-Rd, US-DARZALEX FASPROยฎ-Rd Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma NCT06974786Phase 211 sites๐Ÿ“ Birmingham๐Ÿ“ Denver๐Ÿ“ Iowa City SCRI Development Innovations, LLC ยท Tests: Elranatamab, Daratumumab, Lenalidomide, autologous stem cell transplantation ASCT in Combination With C-CAR088 for Treating Patients With Ultra High-risk Multiple Myeloma (MM) NCT05632380Phase 1, Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Autologous hematopoietic stem cell transplantation, C-CAR088 CM336 Plus Isatuximab for Newly Diagnosed Multiple Myeloma With Renal Impairment NCT07585760Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: CM336 Plus Isatuximab Human BCMA Targeted T Cells Injection๏ผˆBCMA CAR-T๏ผ‰for Subjects With R/R MM NCT05594797Phase 22 sites๐Ÿ“ Shanghai๐Ÿ“ Wenzhou Hrain Biotechnology Co., Ltd. ยท Tests: Human BCMA Targeted T Cells Injection Universal CAR-T Cell Therapy for MM NCT07248176NA1 site๐Ÿ“ Shanghai Bioray Laboratories ยท Tests: Targeted BCMA Gene-Modified Allogeneic Chimeric Antigen Receptor T-Cell Injection The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies NCT05618041NA1 site๐Ÿ“ Taiyuan Hebei Senlang Biotechnology Inc., Ltd. ยท Tests: CAR-T Autologous T cell injection A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects NCT07280013Phase 120 sites๐Ÿ“ Gilbert๐Ÿ“ Sacramento๐Ÿ“ Santa Monica C4 Therapeutics, Inc. ยท Tests: Cemsidomide, Elranatamab
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy